글로벌 EPA 및 DHA 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 EPA 및 DHA 시장

EPA 및 DHA 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge 시장 조사에 따르면 시장이 2021년부터 2028년까지의 예측 기간 동안 8.95%의 CAGR로 성장하고 있다고 분석합니다. 클린 라벨 제품 의 등장으로 EPA 및 DHA 시장 성장이 가속화되고 있습니다.

바로 먹을 수 있는 음식은 식물과 동물에서 추출한 음식을 말하며, 처음에는 씻은 다음 조리합니다. 식품은 냉동되고 직접 가열한 후 소비되도록 가공됩니다. 이 과정은 고객의 에너지와 시간을 절약하는 것으로 알려져 있습니다. 요즘 사람들은 바쁜 직장 생활 때문에 전통적인 대량 식사보다 영양이 풍부한 소량의 바로 먹을 수 있는 음식을 선호합니다.

The increase in demand for the DHA product and its incorporation in infant formulae and nutritional products promoting children's health as are known to be an essential building block for the growth and maturation of an infant's brain and retina acts as the major factor driving the growth of EPA and DHA market. The extensive use of the products obtained from fish and algae oils in fortified foods and dietary supplements and the utilization of the components in the treatment for chronic diseases such as coronary artery disease (CAD), Type 2 diabetes, attention deficit-hyperactivity disorder (ADHD) and dementia accelerate the EPA and DHA market growth. The integration of DHA in geriatric nutrition products, owning to their healthy aging-related benefits, rising penetration of omega 3 in the active pharmaceutical ingredient (API) market and favorable regulations and policies encouraging the use of formulations in in infant nutrition influence the EPA and DHA market. Additionally, the growth in population and geriatric population globally, increasing prevalence of chronic diseases, rise in awareness regarding diseases and treatment among people and surge in disposable income positively affect the EPA and DHA market. Furthermore, research and development activities for obtaining alternative sources and increasing demand for plant-based products extends profitable opportunities to the EPA and DHA market players in the forecast period of 2021 to 2028.   

On the other hand, the fluctuation in the prices and high cost associated with the research and development activities are factors expected to obstruct the EPA and DHA market growth. The rise in concerns regarding the mild side effects of EPA and DHA supplements and lack of clarity among consumers about daily recommended intake are projected to challenge the EPA and DHA market in the forecast period of 2021-2028.  

This EPA and DHA market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on EPA and DHA market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

EPA and DHA Market Scope and Market Size

The EPA and DHA market is segmented on the basis of concentration type, type, form, source and application. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.    

• On the basis of type, the EPA and DHA market is segmented into eicosapentaenoic acid and docosahexaenoic acid.
• On the basis of concentration type, the EPA and DHA market is segmented into high concentrated, medium concentrated and low concentrated.
• On the basis of form, the EPA and DHA market is segmented into triglycerides and ethyl esters.
• On the basis of source, the EPA and DHA market is segmented into anchovy/sardine oils, high concentrates, medium concentrates, low concentrates, algae oils, tuna oils, cod liver oils, salmon oils, krill oils, mehaden oils.
• On the basis of application, the EPA and DHA market is segmented into infant formulae, dietary supplements, fortified food and beverages and pharmaceuticals.

Global EPA and DHA Market Country Level Analysis

The EPA and DHA market is analyzed and market size, volume information is provided by country, concentration type, type, form, source and application as referenced above.      

The countries covered in the global EPA and DHA market report are the U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the EPA and DHA market because of the advancements in products and technologies, increasing investments by key players, customizations of EPA and DHA applications in pharmaceutical and dietary supplements and consumer preference towards the consumption of supplements instead of functional food in the region. Europe is expected to witness the significant CAGR during the forecast period of 2021-2028 because of the high consumption of product, especially in the form of dietary supplements and rise in geriatric population in the region.

EPA 및 DHA 시장 보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 추세에 영향을 미치는 규제 변화를 제공합니다. 소비량, 생산 현장 및 양, 수입 수출 분석, 가격 추세 분석, 원자재 비용, 하류 및 상류 가치 사슬 분석과 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 EPA 및 DHA 시장 점유율 분석

EPA 및 DHA 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 EPA 및 DHA 시장과 관련된 회사의 초점에만 관련이 있습니다.

EPA 및 DHA 시장 보고서에서 다루는 주요 기업은 DSM, ADM, Cargill, Incorporated, BASF SE, Epax, Lonza, Orkla, Corbion, KD Pharma Group SA, GC Rieber, Guangdong Runke Bioengineering Co. Ltd., Nordic Naturals, GOLDEN OMEGA, Biosearch life, Pharma Marine AS, Polaris Inc., Sinomega Biotech Engineering Co., Ltd, Huatai Biopharm Resource Co.,Ltd., KinOmega Biopharm Inc, AlgiSys 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-30029